AbbVie and Cugene Announce Collaboration in Autoimmune Diseases
Go back to AbbVie and Cugene Announce Collaboration in Autoimmune Diseases| AbbVie (NYSE: ABBV) | Delayed: 258.15 -4.75 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.90 | 52 Week High | $68.12 | |||
| Open | $260.81 | 52 Week Low | $50.71 | |||
| Day High | $262.50 | P/E | 56.00 | |||
| Day Low | $257.25 | EPS | $4.61 | |||
| Volume | 4,765,697 | |||||
